IndyGeneUS, Afya Rekod partner on health data platform

0
69
IndyGeneUS Afya Rekod
PHOTO/COURTESY

IndyGeneUS AI has partnered with Kenyan based health data company Afya Rekod, to unveil a new Genomics-Integrated health data platform.

“This partnership will be a great leap for Africa in the area of genomics, patient management, and precision medicine,” said Afya Rekod founder John Kamara.

Afya Rekod is utilizing revolutionary blockchain and cutting-edge artificial intelligence technologies to facilitate better healthcare outcomes for its subscribers in Kenya and across Africa. 

“The collaboration will open new opportunities for doctors, patients and also pharmaceutical companies to better understand the patient-driven economy that is revolutionizing healthcare and how to make sure Africa is at the forefront of using technology and research to improve healthcare”. Kamara added.

IndyGeneUS will leverage the power of whole-genome sequencing in combination with patient-centered health data and electronic health records to create a unique resource for research on conditions affecting Kenyans, Africans, and diaspora populations. Based in Nairobi, IndyGeneUS was founded by Yusuf Henriques, an American public health expert and Howard University graduate, to address the lack of diversity in drug discovery using genomics.

“The opportunity to save lives using genomics is enormous. We are creating Africa’s first secure health and genomics digital platform that will democratize access to accelerate discoveries and the implementation of precision health innovation across the continent.” Henriques said.

Afya Rekod recently partnered with Telkom K Kenya in efforts to expand its userbase to over 2 million participants by the end of this year. IndyGeneUS will enrol participants from Afya Rekod’s rapidly growing userbase to reach our goal of 1 million genomes and establish the world’s largest and most diverse repository of the African diaspora and indigenous genetic data.

ALSO READ: Equity Afia opens 7 more medical centers

LEAVE A REPLY

Please enter your comment!
Please enter your name here